Pomalidomide plus low-dose dexamethasone in patients with relapsed/refractory multiple myeloma and moderate renal impairment: a pooled analysis of three clinical trials

Siegel, David S.; Weisel, Katja C.; Dimopoulos, Meletios A.; Baz, Rachid; Richardson, Paul; Delforge, Michel; Song, Kevin W.; San Miguel, Jesus F.; Moreau, Philippe; Goldschmidt, Hartmut; Cavo, Michele; Jagannath, Sundar; Yu, Xin; Hong, Kevin; Sternas, Lars; Zaki, Mohamed; Palumbo, Antonio

dc.contributor.author	Weisel, Katja
dc.date.accessioned	2018-09-18T08:17:40Z
dc.date.available	2018-09-18T08:17:40Z
dc.date.issued	2016
dc.identifier.issn	1029-2403
dc.identifier.uri	http://hdl.handle.net/10900/84220
dc.language.iso	en	de_DE
dc.publisher	Taylor & Francis Ltd	de_DE
dc.relation.uri	http://dx.doi.org/10.1080/10428194.2016.1177181	de_DE
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	610	de_DE
dc.title	Pomalidomide plus low-dose dexamethasone in patients with relapsed/refractory multiple myeloma and moderate renal impairment: a pooled analysis of three clinical trials	de_DE
dc.type	Article	de_DE
utue.quellen.id	20180405102126_00313
utue.publikation.seiten	2833-2838	de_DE
utue.personen.roh	Siegel, David S.
utue.personen.roh	Weisel, Katja C.
utue.personen.roh	Dimopoulos, Meletios A.
utue.personen.roh	Baz, Rachid
utue.personen.roh	Richardson, Paul
utue.personen.roh	Delforge, Michel
utue.personen.roh	Song, Kevin W.
utue.personen.roh	San Miguel, Jesus F.
utue.personen.roh	Moreau, Philippe
utue.personen.roh	Goldschmidt, Hartmut
utue.personen.roh	Cavo, Michele
utue.personen.roh	Jagannath, Sundar
utue.personen.roh	Yu, Xin
utue.personen.roh	Hong, Kevin
utue.personen.roh	Sternas, Lars
utue.personen.roh	Zaki, Mohamed
utue.personen.roh	Palumbo, Antonio
dcterms.isPartOf.ZSTitelID	Leukemia & Lymphoma	de_DE
dcterms.isPartOf.ZS-Issue	12	de_DE
dcterms.isPartOf.ZS-Volume	57	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE